Rituximab — Dosing in CKD & Dialysis

Rituximab (Monoclonal Antibody): renal dosing adjustments, dialyzability (Negligible (not removed by hemodialysis: rituximab was not detected in the dialysate of a patient on hemodialysis; Jillella 2002, PMID 12410580)), and renal-relevant safety risk for CKD and dialysis patients. Educational refer

Reviewed by Matt · November 16, 2026

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.